| Sponsored by |
 |
By working together foundations and life science companies can have a profound impact on patient lives. This plenary will engage our audience in a meaningful discussion of how foundations and industry can jointly accelerate research and clinical development, impact regulatory processes and overcome barriers to progress in bringing new treatments to patients. It will discuss how to maintain or increase funding of medical innovation in these challenging times.
Keynote:
John F. Crowley
Chairman, President and CEO
Amicus Therapeutics, Inc.
